Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell
• Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Piper Sandler Upgrades Pulmonx to Overweight, Announces $45 Price Target
Piper Sandler analyst Jason Bednar upgrades Pulmonx (NASDAQ:LUNG) from Neutral to Overweight and announces $45 price target.
Pulmonx Q3 EPS $(0.28) Beats $(0.37) Estimate, Sales $13.30M Beat $13.18M Estimate
Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.37) by 24.32 percent. This is a 79.56 percent increase over losses of $(1.37) per share from the same
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Chief Financial Officer Of Pulmonx Makes $224.56 Thousand Sale
Derrick Sung, Chief Financial Officer at Pulmonx (NASDAQ:LUNG), made a large insider sell on September 21, according to a new SEC filing.
Pulmonx Announces Anthem Blue Cross Blue Shield Now Provides Coverage For Severe COPD/Emphysema Treatment
Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for severe lung disease, today announced that Anthem Blue Cross Blue Shield (BCBS) has issued a positive coverage